QANDLI DIABET KASALLIGI: KLINIKASI VA DAVOSI
Keywords:
qandli diabet, klinik belgilar, giperglikemiya, insulin, insulin terapiyasi, glyukoza, glyukozani nazorat qilish, gipopgikemiya, diabetik ketoatsidoz, surunkali asoratlar, diabetik nefropatiya, diabetik retinopatiya, diabetik neyropatiya, dori vositalari, parhez, jismoniy faollik, hayot tarzi o‘zgarishi, kasallikni boshqarish, zamonaviy davolash usullari.Abstract
Mazkur maqolada qandli diabet (diabetes mellitus) kasalligini keltirib chiqaruvchi sabablari, uning klinik belgilari, turlari, tashxislash usullari va zamonaviy davolash usullari haqida ma’lumot berilgan. Shuningdek, profilaktik choralar va bemorlar hayot sifatini yaxshilashga qaratilgan tavsiyalar keltirilgan. Maqola tibbiyot yo‘nalishida tahsil olayotgan talabalar va amaliyotdagi mutaxassislar uchun foydalidir.
References
1. World Health Organization. Global report on diabetes. Geneva: WHO; 2016.
2. American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care.
3. Мухина Н.А. Эндокринология. Учебник. Москва: ГЭОТАР-Медиа, 2023.
4. O‘zbekiston Respublikasi sog‘liqni saqlash vazirligi. "Qandli diabet bo‘yicha klinik protokollar", 2022.
5. Atakhanova, N. E., Almuradova, D. M., Ziyayev Sh, V., Хамидов, Х., & Юсупов, А. (2023). Значения андрогенных рецепторов для прогнозирования выживаемости больных трижды негативным раком молочной железы. International Bulletin of Medical Sciences and Clinical Research, 3(6), 5-8.
6. Almuradova, D. M., Mukumova, D. I., & Turaeva, X. K. (2022). Karlibaev AO Modern endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer. Образования и наука в ХХI веке, 24(2), 773-780.
7. Juraev, M. D., Atakhanova, N. E., Almuradova, D. M., & Gaziev, L. T. (2023). Androgen receptor values for prediction of survival of patients with three times negative breast cancer. EPRA International Journal of Research and Development (IJRD), 8(6), 104-106.
8. Tursunova, N. I., Almuradova, D. M., Turayeva Kh, K. H., & Muqimova, D. I. (2022). Hereditary breast and ovarian cancer. EDUCATION AND SCIENCE IN THE XXI CENTURY, (24), 1200-1212.
9. Атаханова, Н. Э., & Алмурадова, Д. М. (2022). Влияние экспрессии андрогеновых рецепторов на прогноз трижды негативного рака молочной железы. Клиническая и экспериментальная онкология, 10(2), 112-115.
10. Almuradova, D. M., Sh, O. S., & Ubaydullaev, I. A. (2021). Sharobiddinov BB Islamov SB A Modern Approach to Diagnosis and Treatment of Breast Cancer Releases. Central Asian Journal of Medical and Natural Science, 2(5), 294-298.
11. Tilyashaikhov, M. N., Gaziev, L. T., Almuradov, A., & Almuradova, D. M. (2021). A Modern Approach to Diagnostics, Prediction and Course of Renal Cell Cancer. Annals of the Romanian Society for Cell Biology, 25(1), 4429-4451.
12.Khakimova, G. G., Khakimov, G. A., Khakimova, S. G., Khakimov, A. T., & Almuradova, D. M. (2021). Changes In Tumor Infiltrating Lymphocytes Of Peripheral Blood And Tissue During Chemotherapy In Patients With Gastric Cancer. The American Journal of Medical Sciences and Pharmaceutical Research, 3(03), 20-31.
13. Almuradova, D. M. (2018). THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER. Journal of Drug Delivery & Therapeutics, 8(5), 163-167.
14.Atakhanova, N. E., Almuradova, D. M., Tursunova, N. I., & Ziyaev, S. V. (2023). Triple negative breast cancer and drug-resistant cells. World bulletin of public health (WBPH) in, 28.
15.Атаханова, Н. Э., Турсунова, Н. И., Яхяева, В. К., Эсонтурдиев, У. И., Мамажанов, Х. И., Алмурадова, Д. М., & Ботиралиева, Г. К. (2023). Клинический случай хирургического лечения злокачественной опухоли из оболочек периферических нервов забрюшинной локализации. Тазовая хирургия и онкология, 13(4), 62-67.
16.Atakhanova, N. E., Almuradova, D. M., Gaziev, L. T., & Ziyayev Sh, V. (2023). Results of Drug Treatment of patients with metastasis of triple times negative breast cancer. EPRA International Journal of Research and Development (IJRD), 9(6), 125-128.
17. Tillyashaykhov M.N., Azizov B.R. “Ichki kasalliklar propedevtikasi”, Toshkent, 2021.
